Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Commercial Milestone Payments

No definition available.

Name:	exel_CollaborativeArrangementRightsAndObligationsMaximumAggregateCommercialMilestonePayments
Namespace Prefix:	exel_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Development Milestone Payments

+ References

No definition available.

+ Details

Name:	exel_CollaborativeArrangementRightsAndObligationsMaximumAggregateDevelopmentMilestonePayments
Namespace Prefix:	exel_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Regulatory Milestone Payments

+ References

No definition available.

+ Details

Name:	exel_CollaborativeArrangementRightsAndObligationsMaximumAggregateRegulatoryMilestonePayments
Namespace Prefix:	exel_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Rights And Obligations, Upfront Payment

+ References

No definition available.

+ Details

Name:	exel_CollaborativeArrangementRightsAndObligationsUpfrontPayment
Namespace Prefix:	exel_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=exel_CollaborationAgreementWithBioInventInternationalABBioInventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=exel_CollaborationAgreementWithRyvuTherapeuticsSARyvuMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=exel_ResearchCollaborationsInLicensingArrangementsAndOtherBusinessDevelopmentActivitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Collaboration Agreements And Business Development Activities - Research Collaborations and In-Licensing Arrangements Narrative (Details) - USD ($) $ in Millions	1 Months Ended
	Jul. 31, 2022	Jun. 30, 2022	Sep. 30, 2022
Collaboration Agreement With BioInvent International AB (BioInvent)
Asset Acquisition [Line Items]
Collaborative arrangement, upfront payment		$ 25.0
Collaboration Agreement With Ryvu Therapeutics S.A. (Ryvu)
Asset Acquisition [Line Items]
Collaborative arrangement, upfront payment	$ 3.0
Research Collaborations, In-Licensing Arrangements and Other Business Development Activities
Asset Acquisition [Line Items]
Collaborative arrangement, maximum aggregate development milestone payments			$ 364.7
Collaborative arrangement, maximum aggregate regulatory milestone payments			453.4
Collaborative arrangement, rights and obligations, maximum aggregate commercial milestone payments			$ 2,443.4